Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,766 GBX | +2.11% | -0.65% | +21.81% |
05:01pm | US FDA approves Moderna's RSV vaccine, its second marketed product | RE |
May. 30 | Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.81% | 89.9B | |
+39.47% | 734B | |
+32.83% | 591B | |
-6.13% | 350B | |
+14.95% | 315B | |
+2.24% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+5.71% | 161B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Bernstein Lifts GSK PT, Keeps Outperform Rating